" "plan," "anticipate," "intend," "believe," "estimate," "predict,"
"project," "potential," "continue," "target" and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. Any
forward-looking statements in this press release, are based on
management's current expectations and beliefs and are subject to a
number of risks, uncertainties and important factors that may cause
actual events or results to differ materially from those expressed or
implied by any forward-looking statements contained in this press
release, including, without limitation, uncertainties related to market
conditions. These and other risks and uncertainties are described in the
Company's Annual Report on Form 20-F filed with the SEC on March 11,
2021, as well as market conditions and regulatory review.
Any forward-looking statements contained in this press release represent
Addex Therapeutics' views only as of the date hereof and should not be
relied upon as representing its views as of any subsequent date. Addex
Therapeutics explicitly disclaims any obligation to update any
forward-looking statements, except as required by law.
(END) Dow Jones Newswires
May 05, 2021 01:00 ET (05:00 GMT)